HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chester A Metcalf Selected Research

BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)

6/2010Discovery of 3-[2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide (AP24534), a potent, orally active pan-inhibitor of breakpoint cluster region-abelson (BCR-ABL) kinase including the T315I gatekeeper mutant.
11/2009AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance.
6/2006Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance.
10/2004Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chester A Metcalf Research Topics

Disease

9Neoplasms (Cancer)
07/2022 - 09/2003
5Bone Diseases (Bone Disease)
10/2006 - 01/2002
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2010 - 10/2004
4Osteoporosis
10/2006 - 09/2003
3Bone Resorption
10/2006 - 09/2003
2Carcinoma (Carcinomatosis)
09/2006 - 02/2005
2Neoplasm Metastasis (Metastasis)
12/2005 - 09/2003
1Ovarian Neoplasms (Ovarian Cancer)
09/2006
1Adenocarcinoma
12/2005
1Systemic Mastocytosis
07/2005
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
07/2005
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2005
1Colonic Neoplasms (Colon Cancer)
02/2005

Drug/Important Bio-Agent (IBA)

8src-Family KinasesIBA
10/2006 - 01/2002
6Phosphotransferases (Kinase)IBA
06/2010 - 01/2002
3EnzymesIBA
10/2006 - 09/2003
2Focal Adhesion Protein-Tyrosine KinasesIBA
07/2022 - 02/2005
2Imatinib Mesylate (Gleevec)FDA Link
11/2009 - 06/2006
2Diphosphonates (Bisphosphonates)IBA
10/2006 - 09/2003
2AP23846IBA
09/2006 - 12/2005
2Adenosine Triphosphate (ATP)IBA
12/2005 - 09/2003
1Therapeutic UsesIBA
11/2019
1cabazitaxelFDA Link
11/2019
1Antineoplastic Agents (Antineoplastics)IBA
11/2019
1hexanoic acid (hexanoate)IBA
11/2019
1Dasatinib (BMS 354825)FDA Link
11/2009
1nilotinibFDA Link
11/2009
1ponatinibIBA
11/2009
1Docetaxel (Taxotere)FDA Link
09/2006
1Proliferating Cell Nuclear Antigen (PCNA)IBA
09/2006
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
09/2006
1Interleukin-8 (Interleukin 8)IBA
12/2005
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2005
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
07/2005
1AP23848IBA
07/2005
1AP23464IBA
07/2005
1Proteins (Proteins, Gene)FDA Link
02/2005
1bcr-abl Fusion ProteinsIBA
10/2004
1AP22408IBA
09/2003
1PurinesIBA
09/2003
1LigandsIBA
09/2003
1AP23236IBA
09/2003
1Zoledronic Acid (Zometa)FDA Link
09/2003
1Alendronate (Alendronate Sodium)FDA LinkGeneric
09/2003
1Protein Kinases (Protein Kinase)IBA
01/2002

Therapy/Procedure

4Therapeutics
11/2009 - 09/2003